Company Search:
Advanced Search
Sponsored Links
Glaxo Smith Kline Company Snapshot
Glaxo Smith Kline operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Glaxo Smith Kline with three other companies in this sector in Egypt: Alexandria Pharmaceuticals and Chemical Industries Co (2015 sales of 382.89 million Egyptian Pounds [US$21.21 million] ), Memphis Pharmaceutical & Chemical Industries (396.15 million Egyptian Pounds [US$21.95 million] ), and Egypt International Pharmaceuticals (1.70 billion Egyptian Pounds [US$94.01 million] of which 100% was Pharmaceutical).

Sales Analysis. During the year ended December of 2015, sales at Glaxo Smith Kline were 1.02 billion Egyptian Pounds (US$56.56 million). This is a decrease of 3.9% versus 2014, when the company's sales were 1.06 billion Egyptian Pounds.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Glaxo Smith Kline
  Stock Performance Chart for Glaxo Smith Kline
  Stock Data: Recent Stock Performance:
  Current Price (3/23/2017): 11.72
(Figures in Egyptian Pounds)
1 Week n/a   13 Weeks 18.5%  
4 Weeks 18.6%   52 Weeks 29.5%  
Glaxo Smith Kline Key Data:
  Ticker: BIOC Country: Egypt
  Exchanges: CAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 1,020,948,163
(Year Ending Jan 2016).
Employees: N/A
  Currency: Egyptian Pounds Market Cap: 978,786,424
  Fiscal Yr Ends: December Shares Outstanding: 83,514,200
  Share Type: Ordinary Closely Held Shares: 81,079,928
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.